The Checkup with Doctor Mike Will Ozempic Put An End To Weight Loss Surgery? | Dr. Christine Ren-Fielding
42 snips
Nov 20, 2024 Dr. Christine Ren-Fielding, Chief of Bariatric Surgery at NYU Langone Health, discusses the future of weight loss approaches. She delves into the impact of GLP-1 medications like Ozempic, questioning if they could replace traditional bariatric surgery. The conversation covers the intricate relationship between set point theory, food addiction, and psychological factors affecting weight loss. Dr. Ren-Fielding also shares insights on the success rates of surgery and patient experiences, shedding light on societal perceptions and common misconceptions surrounding obesity treatment.
AI Snips
Chapters
Transcript
Episode notes
Bariatric Surgery Explained
- Bariatric surgery manipulates internal organs to control hunger and portion sizes.
- It's crucial to combine surgery with nutritional guidance and psychological evaluation to address emotional eating patterns.
Bariatric Surgery and Public Perception
- Dr. Mike has faced criticism for discussing bariatric surgery, being labeled "fatphobic."
- Dr. Ren-Fielding highlights the life-altering benefits of surgery, including extended lifespan and improved quality of life.
BMI and Bariatric Surgery
- BMI is a useful, but imperfect, tool for assessing bariatric surgery candidacy.
- It can discriminate against certain ethnicities who develop obesity-related illnesses at lower BMIs due to visceral fat.